Skip to main content
. 2022 Jan 19;14(2):789–799. doi: 10.18632/aging.203840

Table 1. Baseline characteristics of the training set and validation set.

Features Training set (n=151) Validation set (n=134) P-value
Age(years) 48.88±14.46 53.22±14.52 0.012
Sex 0.104
Male 103(68.2%) 78(58.2%)
Female 48(31.8%) 56(41.8%)
Etiology 0.192
Trauma 74(49.0%) 75(56.0%)
Stroke 67(44.4%) 46(34.3%)
Anoxia 10(6.6%) 13(9.7%)
CRS-R total score 5.00(3.00, 8.00) 5.00(2.00, 8.00) 0.771
GCS total score 9.00(7.00, 9.00) 8.00(6.00, 9.00) 0.208
Serum albumin(g/L) 37.48±4.14 36.67±4.45 0.111
Hemoglobin(g/L) 113.11±15.83 107.69±15.42 0.004
Basic cardiopulmonary diseases 0.521
Presence 18(11.9%) 12(9.0%)
Absence 133(88.1%) 122(91.0%)
Level of consciousness 0.604
VS 97(64.2%) 90(67.2%)
MCS 54(35.8%) 44(32.8%)
Multiple injuries 0.854
Presence 38(25.2%) 35(26.1%)
Absence 113(74.8%) 99(73.9%)
EEG background activity 0.288
Lack of alpha rhythms 75(49.7%) 75(56%)
Alpha rhythms exists 76(50.3%) 59(44%)
N20 on SEP 0.841
Presence 122(80.8%) 107(79.9%)
One or both absent 29(19.2%) 27(20.1%)
BAEP grade 0.006
GradeI-II 82(54.3%) 51(38.1%)
GradeIII-IV 69(45.7%) 83(61.9%)
Midline shift 0.848
Presence 18(11.9%) 15(11.2%)
Absence 133(88.1%) 119(88.8%)
Hypertension 0.724
Presence 48(31.8%) 40(29.9%)
Absence 103(68.2%) 94(70.1%)
Smoking history 0.718
Presence 19(12.6%) 15(11.2%)
Absence 132(87.4%) 119(88.8%)
Cholesterol 0.203
>5.17mmol/L 16(10.6%) 21(15.7%)
≤5.17mmol/L 135(89.4%) 113(84.3%)
Triglyceride 0.747
>1.70mmol/L 48(31.8%) 45(33.6%)
≤1.70mmol/L 103(68.2%) 89(66.4%)
Outcome 0.242
Good outcomes 54(35.8%) 57(42.5%)
Adverse outcomes 97(64.2%) 77(57.5%)